Tilray | TRLY - Kapitał Własny I Rezerwy

Cena Akcji
9.26
Dzienna Zmiana
0.11 1.20%
Miesięcznie
-1.91%
Rocznie
1,282.09%
Q2 Prognozy TE
8.94




Kapitał Własny I Rezerwy Zmiana Data
Acasti Pharma USD 62.82M 732K 2025-09
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Canopy Growth CAD 758.17M 22.16M 2025-12
Cronos Group USD 1.09B 11.39M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
IQVIA Holdings USD 6.5B 343M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Moderna USD 8.65B 680M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Organon & Co USD 906M 173M 2025-09
Revvity USD 7.38B 180.27M 2025-09
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12